C. R. Bard Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (22)

Latest Posts

About This Stock More About This Stock
CR Bard Inc. To Be Acquired By Becton Dickinson And Co. For $24 Billion
Article By: Lorimer Wilson
Monday, April 24, 2017 10:42 AM EST
CR Bard Inc. has agreed to be acquired by fellow medical devices giant Becton Dickinson and Co. for $24 billion in cash and stock.
In this article: BCR, BDX
Read
Premarket Biotech Digest – BDX Finalizes Acquisition Deal, VNLPF Receives CRL, EYEG Files S-1
Article By: KKD Healthcare Analytics
Monday, April 24, 2017 10:03 AM EST
Johnson & Johnson announced results from a Phase 2 clinical trial assessing the triple combination ofOlysio (simeprevir), C.R. Bard Inc. and Becton Dickinson finalize the deal for buying Bard.
In this article: BCR, JNJ, MRK, NVO, VNLPF, XOMA, EYEG, ARGNF, BDX
Read
Top 15 Low-Volatility Dividend Aristocrats
Article By: SureDividend
Monday, April 3, 2017 5:11 PM EST
Will present the top 15 Dividend Aristocrats with the lowest stock price volatility.
In this article: JNJ, ABT, BCR, HRL, BDX, WMT, CL, MCD, MKC, KO, PG, PEP, ED, CLX, KMB
Read
Dividend Income Update November 2016
Article By: Keith Park
Sunday, December 4, 2016 9:02 PM EST
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolios.
In this article: ABT, APD, BCR, CAT, CL, CLX, GIS, HCN, HCP, PG, RY, TD, YUM, ABBV
Read
Dividend Aristocrats In Focus Part 25: CR Bard
Article By: SureDividend
Tuesday, November 1, 2016 12:51 PM EST
CR Bard is a shareholder friendly stock, despite its low yield.The company’s management prefers to return cash to shareholders through share repurchases rather than dividends.
In this article: BCR
Read

PARTNER HEADLINES

Latest Tweets for $BCR

No tweets yet!